No Data Available
AusCann Group Holdings Ltd (AC8)
is a publicly listed company on the Australian Securities Exchange (ASX).
They believe Australian patients have the right to access high quality, cost effective, cannabinoid medicines.
Quality Control is Their no.1 Priority
Ensuring 'good manufacturing practices', they are committed to supplying their clients with a consistent & reliable source of high-quality medical cannabis.
AusCann brings together a strong team with relevant & complementary skill-sets, experiences and networks.
Why Medicinal Cannabis
For over 12,000 years, the Cannabis plant has provided humankind with food, fibre, and medicine.
Global sentiment is changing with an increasing number of jurisdictions legislating in favour of the use of Cannabis for medical purposes.
Numerous applications include anti-convulsion, neuroprotectant, anti-inflammatory, anti-nausea, glaucoma, pain management & appetite stimulation are important areas.
Hundreds of clinical studies and significant first hand evidence are demonstrating the medical benefits of this ancient traditional medicine.
AusCann Group Holdings Ltd
85 Carabooda Road
+61 8 9561 8834
Fax: +61 8 6255 5031
The General Overview, Services, Products and Projects information for this profile was last edited on 30 Jan 2017.